Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns

Keiji Yamana, Ichiro Morioka, Daisuke Kurokawa, Sachiyo Fukushima, Kosuke Nishida, Shohei Ohyama, Noriyuki Nishimura, Kandai Nozu, Mariko Ikeda, Hiroaki Nagase, Kazumichi Fujioka, Sota Iwatani, Hajime Nakamura, Kazumoto Iijima

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Non-invasive transcutaneous bilirubin (TcB) monitoring has been widely used to screen for hyperbilirubinemia. TcB measured using the recently developed BiliCare™ system, however, has not been fully evaluated. Methods: One hundred and seven TcB measurements were obtained from 82 Japanese newborns ≥35 weeks’ gestational age within 2 weeks after birth. Measurements were taken at the scaphoid fossa, conchal cavity, and lobe of the ear using BiliCare. BiliCare TcB were compared with total serum bilirubin (TB) and TcB obtained using another bilirubinometer (JM-105™). Results: Transcutaneous bilirubin measured at all three sites significantly correlated with TB (r = 0.91, 0.93, and 0.93 at the scaphoid fossa, conchal cavity, and lobe, respectively). The mean differences were 0.1, −0.3, and 3.6 at the scaphoid fossa, conchal cavity, and lobe, respectively. BiliCare TcB at the scaphoid fossa significantly correlated with that using the JM-105 (r = 0.91). The mean difference was 0.0. BiliCare, however, produced a significantly higher and lower TcB than the JM-105 for TB <7 and ≥15 mg/dL, respectively. Conclusions: Transcutaneous bilirubin measurements taken at the scaphoid fossa or conchal cavity using BiliCare were more reliable than those at the earlobe. BiliCare TcB differed from those of the JM-105, for TB <7 or ≥15 mg/dL.

Original languageEnglish
Pages (from-to)1058-1063
Number of pages6
JournalPediatrics International
Volume59
Issue number10
DOIs
Publication statusPublished - 01-10-2017

Fingerprint

Bilirubin
Newborn Infant
Equipment and Supplies
Serum
Hyperbilirubinemia
Gestational Age
Ear
Parturition

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Yamana, K., Morioka, I., Kurokawa, D., Fukushima, S., Nishida, K., Ohyama, S., ... Iijima, K. (2017). Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns. Pediatrics International, 59(10), 1058-1063. https://doi.org/10.1111/ped.13364
Yamana, Keiji ; Morioka, Ichiro ; Kurokawa, Daisuke ; Fukushima, Sachiyo ; Nishida, Kosuke ; Ohyama, Shohei ; Nishimura, Noriyuki ; Nozu, Kandai ; Ikeda, Mariko ; Nagase, Hiroaki ; Fujioka, Kazumichi ; Iwatani, Sota ; Nakamura, Hajime ; Iijima, Kazumoto. / Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns. In: Pediatrics International. 2017 ; Vol. 59, No. 10. pp. 1058-1063.
@article{67680b3276774e3489aac3a4e0caed44,
title = "Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns",
abstract = "Background: Non-invasive transcutaneous bilirubin (TcB) monitoring has been widely used to screen for hyperbilirubinemia. TcB measured using the recently developed BiliCare™ system, however, has not been fully evaluated. Methods: One hundred and seven TcB measurements were obtained from 82 Japanese newborns ≥35 weeks’ gestational age within 2 weeks after birth. Measurements were taken at the scaphoid fossa, conchal cavity, and lobe of the ear using BiliCare. BiliCare TcB were compared with total serum bilirubin (TB) and TcB obtained using another bilirubinometer (JM-105™). Results: Transcutaneous bilirubin measured at all three sites significantly correlated with TB (r = 0.91, 0.93, and 0.93 at the scaphoid fossa, conchal cavity, and lobe, respectively). The mean differences were 0.1, −0.3, and 3.6 at the scaphoid fossa, conchal cavity, and lobe, respectively. BiliCare TcB at the scaphoid fossa significantly correlated with that using the JM-105 (r = 0.91). The mean difference was 0.0. BiliCare, however, produced a significantly higher and lower TcB than the JM-105 for TB <7 and ≥15 mg/dL, respectively. Conclusions: Transcutaneous bilirubin measurements taken at the scaphoid fossa or conchal cavity using BiliCare were more reliable than those at the earlobe. BiliCare TcB differed from those of the JM-105, for TB <7 or ≥15 mg/dL.",
author = "Keiji Yamana and Ichiro Morioka and Daisuke Kurokawa and Sachiyo Fukushima and Kosuke Nishida and Shohei Ohyama and Noriyuki Nishimura and Kandai Nozu and Mariko Ikeda and Hiroaki Nagase and Kazumichi Fujioka and Sota Iwatani and Hajime Nakamura and Kazumoto Iijima",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/ped.13364",
language = "English",
volume = "59",
pages = "1058--1063",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "10",

}

Yamana, K, Morioka, I, Kurokawa, D, Fukushima, S, Nishida, K, Ohyama, S, Nishimura, N, Nozu, K, Ikeda, M, Nagase, H, Fujioka, K, Iwatani, S, Nakamura, H & Iijima, K 2017, 'Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns', Pediatrics International, vol. 59, no. 10, pp. 1058-1063. https://doi.org/10.1111/ped.13364

Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns. / Yamana, Keiji; Morioka, Ichiro; Kurokawa, Daisuke; Fukushima, Sachiyo; Nishida, Kosuke; Ohyama, Shohei; Nishimura, Noriyuki; Nozu, Kandai; Ikeda, Mariko; Nagase, Hiroaki; Fujioka, Kazumichi; Iwatani, Sota; Nakamura, Hajime; Iijima, Kazumoto.

In: Pediatrics International, Vol. 59, No. 10, 01.10.2017, p. 1058-1063.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns

AU - Yamana, Keiji

AU - Morioka, Ichiro

AU - Kurokawa, Daisuke

AU - Fukushima, Sachiyo

AU - Nishida, Kosuke

AU - Ohyama, Shohei

AU - Nishimura, Noriyuki

AU - Nozu, Kandai

AU - Ikeda, Mariko

AU - Nagase, Hiroaki

AU - Fujioka, Kazumichi

AU - Iwatani, Sota

AU - Nakamura, Hajime

AU - Iijima, Kazumoto

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background: Non-invasive transcutaneous bilirubin (TcB) monitoring has been widely used to screen for hyperbilirubinemia. TcB measured using the recently developed BiliCare™ system, however, has not been fully evaluated. Methods: One hundred and seven TcB measurements were obtained from 82 Japanese newborns ≥35 weeks’ gestational age within 2 weeks after birth. Measurements were taken at the scaphoid fossa, conchal cavity, and lobe of the ear using BiliCare. BiliCare TcB were compared with total serum bilirubin (TB) and TcB obtained using another bilirubinometer (JM-105™). Results: Transcutaneous bilirubin measured at all three sites significantly correlated with TB (r = 0.91, 0.93, and 0.93 at the scaphoid fossa, conchal cavity, and lobe, respectively). The mean differences were 0.1, −0.3, and 3.6 at the scaphoid fossa, conchal cavity, and lobe, respectively. BiliCare TcB at the scaphoid fossa significantly correlated with that using the JM-105 (r = 0.91). The mean difference was 0.0. BiliCare, however, produced a significantly higher and lower TcB than the JM-105 for TB <7 and ≥15 mg/dL, respectively. Conclusions: Transcutaneous bilirubin measurements taken at the scaphoid fossa or conchal cavity using BiliCare were more reliable than those at the earlobe. BiliCare TcB differed from those of the JM-105, for TB <7 or ≥15 mg/dL.

AB - Background: Non-invasive transcutaneous bilirubin (TcB) monitoring has been widely used to screen for hyperbilirubinemia. TcB measured using the recently developed BiliCare™ system, however, has not been fully evaluated. Methods: One hundred and seven TcB measurements were obtained from 82 Japanese newborns ≥35 weeks’ gestational age within 2 weeks after birth. Measurements were taken at the scaphoid fossa, conchal cavity, and lobe of the ear using BiliCare. BiliCare TcB were compared with total serum bilirubin (TB) and TcB obtained using another bilirubinometer (JM-105™). Results: Transcutaneous bilirubin measured at all three sites significantly correlated with TB (r = 0.91, 0.93, and 0.93 at the scaphoid fossa, conchal cavity, and lobe, respectively). The mean differences were 0.1, −0.3, and 3.6 at the scaphoid fossa, conchal cavity, and lobe, respectively. BiliCare TcB at the scaphoid fossa significantly correlated with that using the JM-105 (r = 0.91). The mean difference was 0.0. BiliCare, however, produced a significantly higher and lower TcB than the JM-105 for TB <7 and ≥15 mg/dL, respectively. Conclusions: Transcutaneous bilirubin measurements taken at the scaphoid fossa or conchal cavity using BiliCare were more reliable than those at the earlobe. BiliCare TcB differed from those of the JM-105, for TB <7 or ≥15 mg/dL.

UR - http://www.scopus.com/inward/record.url?scp=85032329869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032329869&partnerID=8YFLogxK

U2 - 10.1111/ped.13364

DO - 10.1111/ped.13364

M3 - Article

C2 - 28703875

AN - SCOPUS:85032329869

VL - 59

SP - 1058

EP - 1063

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 10

ER -

Yamana K, Morioka I, Kurokawa D, Fukushima S, Nishida K, Ohyama S et al. Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns. Pediatrics International. 2017 Oct 1;59(10):1058-1063. https://doi.org/10.1111/ped.13364